M&A Deal Summary

Kaly Acquires NCM Biotech

On November 15, 2018, Kaly acquired life science company NCM Biotech

Acquisition Highlights
  • This is Kaly’s 1st transaction in the Life Science sector.
  • This is Kaly’s 1st transaction in the United States.
  • This is Kaly’s 1st transaction in Rhode Island.

M&A Deal Summary
Date 2018-11-15
Target NCM Biotech
Sector Life Science
Buyer(s) Kaly
Deal Type Add-on Acquisition

Target

NCM Biotech

Newport, Rhode Island, United States
NCM Biotech is a research and development for the advancement of alternative medicine using naturopathic treatments. NCM Biotech is based in Newport, Rhode Island.

Search 199,713 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Kaly

Dallas, United States
Category Company
Sector Apparel/Textiles
Employees171
Revenue 95M USD (2012)
DESCRIPTION

Kaly is a designer, marketer, and distributor of apparel and related products. Kaly was founded in 2006 and is based in Xiamen, China.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Rhode Island) 1 of 1
Country (United States) 1 of 1
Year (2018) 1 of 1
Mergr

Product

Company

Legal